Effective January 1, 2026, Essity's business areas will be as follows: Health & Medical, Personal Care, Consumer Tissue and Professional Hygiene. The new business areas reflect the organizational ...
EO2401 in vivo immune therapy + nivolumab +/- bevacizumab shows survival benefit in first recurrent glioblastomaData presented at 2025 SNO conference by lead investigator Paris, France – 2 DECEMBER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback